Registered entities
Akebia Therapeutics, Inc.
Reg. No. 208756903United States
Akebia Therapeutics, Inc.
Reg. No. 709018United States
Innovation
47 patent families (16 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 9,745 times.
| Year | Filings |
|---|---|
| 2015 | 7 |
| 2016 | 12 |
| 2017 | 12 |
| 2018 | 9 |
| 2019 | 10 |
| 2020 | 7 |
| 2021 | 15 |
| 2022 | 18 |
| 2023 | 20 |
| 2024 | 12 |
| 2025 | 11 |
| 2026 | 5 |
Social engagement
Social engagement: 42K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
15 investors on record; lead investors include Genechem; 2 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 9 | 60% |
| Private equity | 1 | 7% |
| Angel & family office | 1 | 7% |
| Accelerator & incubator | 1 | 7% |
| Other / undisclosed | 3 | 20% |
Hiring activity
Hires frequently
15 roles tracked across 7 of the last 12 months
23 Apr 2026 · Manager Regulatory Affairs, CMC · Cambridge
17 Apr 2026 · Director of Procurement and Sourcing · Cambridge
13 Apr 2026 · Principal, Medicinal Chemistry · Cambridge
4 Apr 2026 · Senior Manager, Clinical Project Manager · Cambridge
27 Mar 2026 · Product Manager, Marketing · Cambridge
Based on job postings tracked across public sources.
Recent activity
28 May 2026
Event
2026 Jefferies Global Healthcare Conference
8 May 2026
Event
SCM26 #NKFClinicals
8 May 2026
Event
SCM26 #NKFClinicals